Drug - Inhaled Corticosteroids
June 2019
Therapeutic area - Respiratory/Asthma
Drugs
Preferred
Asmanex (twisthaler)
Budesonide respules
Flovent Diskus
Flovent HFA
Pulmicort Flexhaler
Nonpreferred
Alvesco
Armonair Respiclick
Arnuity Ellipta
Asmanex HFA
Pulmicort Respules
QVAR Redihaler
Note: Failure is defined as no improvement or worsening in asthma symptoms after at least two weeks of continued daily use of the inhaled corticosteroid.
Expected side effects of any agent within the class are not considered failure. Expected side effects include:
Exceptions
See Grandfathering Criteria for patient-specific exceptions.
One inhaler per month
MHCP Provider Call Center 651-431-2700 or 800-366-5411